Disinfection of human cardiac valve allografts in tissue banking: systematic review report
- PMID: 27522194
- PMCID: PMC5116039
- DOI: 10.1007/s10561-016-9570-9
Disinfection of human cardiac valve allografts in tissue banking: systematic review report
Abstract
Cardiovascular allografts are usually disinfected using antibiotics, but protocols vary significantly between tissue banks. It is likely that different disinfection protocols will not have the same level of efficacy; they may also have varying effects on the structural integrity of the tissue, which could lead to significant differences in terms of clinical outcome in recipients. Ideally, a disinfection protocol should achieve the greatest bioburden reduction with the lowest possible impact on tissue integrity. We conducted a systematic review of methods applied to disinfect cardiovascular tissues. The use of multiple broad spectrum antibiotics in conjunction with an antifungal agent resulted in the greatest reduction in bioburden. Antibiotic incubation periods were limited to less than 24 h, and most protocols incubated tissues at 4 °C, however one study demonstrated a greater reduction of microbial load at 37 °C. None of the reviewed studies looked at the impact of these disinfection protocols on the risk of infection or any other clinical outcome in recipients.
Keywords: Bioburden; Cardiovascular allografts; Tissue banking; Tissue decontamination; Tissue donation.
Conflict of interest statement
Production of this report has been made possible through a financial contribution from Health Canada, and the Provincial and Territorial governments and has been facilitated by Canadian Blood Services. The views expressed herein do not necessarily represent the views of the Federal, Provincial, Territorial governments or Canadian Blood Services. Funds were provided by Canadian Blood Services to authors from McMaster University for their assistance in performing and writing the systematic review. No conflicts-of-interest were identified on disclosure forms completed by members of the Committee.
References
-
- CDC, C. for D. C. and P (1997) Candida albicans endocarditis associated with a contaminated aortic valve allograft–California, 1996. MMWR. Morb Mortal Wkly Rep 46(12): 261–263. http://www.ncbi.nlm.nih.gov/pubmed/9091782 - PubMed
-
- Chaukar AP, Gogate AS, Patwardhan AM, Kaul A. Use of hamycin in sterilization of aortic homograft valves. Hindustan Antibiot Bull. 1990;32(1–2):27–28. - PubMed
-
- Fan Y-D, Van Hoeck B, Holovska V, Jashari R (2012) Evaluation of decontamination process of heart valve and artery tissues in European Homograft Bank (EHB): a retrospective study of 1055 cases. Cell Tissue Bank 13(2):297–304. http://doi.org/10.1007/s10561-011-9255-3 - DOI - PubMed
-
- Gall K, Smith S, Willmette C, Wong M, O’Brien M (1995) Allograft heart valve sterilization: a six-year in-depth analysis of a twenty-five-year experience with low-dose antibiotics. J Thorac Cardiovasc Surg 110(3):680–687. http://doi.org/10.1016/S0022-5223(95)70099-4 - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical